A protein secreted by tumors, known as ADAMTSL4, plays a central role in cancer cachexia by locally activating the TGF-β signaling pathway in muscle and fat tissue. [1]
Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine, the German Center for Diabetes Research, and the Technical University of Munich identified a previously unknown mechanism that drives cancer cachexia. [2] Dr. Juliano Machado, first author of the study and postdoc at the Institute for Diabetes and Cancer, said that switching off ADAMTSL4 production in tumor cells significantly reduced muscle and fat mass loss in mice. [3] The team found elevated ADAMTSL4 levels in the blood of several mouse models of cancer cachexia and in patients with colorectal and lung cancer. [4]
Dr. Mauricio Berriel Diaz, research group leader at the Institute for Diabetes and Cancer (IDC) at Helmholtz Munich, stated that the team wanted to understand which signals from the tumor trigger the breakdown of muscle and fat tissue. [5]Una proteína secretada por los tumores, conocida como ADAMTSL4, desempeña un papel central en la caquexia cancerosa al activar localmente la vía de señalización de TGF-β en el tejido muscular y adiposo. [1]
Investigadores de Helmholtz Munich, la Facultad de Medicina de Heidelberg, el Centro Alemán para la Investigación de la Diabetes y la Universidad Técnica de Múnich identificaron un mecanismo previamente desconocido que impulsa la caquexia cancerosa. [2] El Dr. Juliano Machado, primer autor del estudio y posdoctorante en el Instituto para la Diabetes y el Cáncer, afirmó que desactivar la producción de ADAMTSL4 en las células tumorales redujo significativamente la pérdida de masa muscular y grasa en ratones. [3] El equipo encontró niveles elevados de ADAMTSL4 en la sangre de varios modelos de ratón con caquexia cancerosa y en pacientes con cáncer colorrectal y de pulmón. [4]
El Dr. Mauricio Berriel Diaz, líder del grupo de investigación en el Instituto para la Diabetes y el Cáncer (IDC) de Helmholtz Munich, declaró que el equipo quería comprender qué señales del tumor desencadenan la degradación del tejido muscular y adiposo. [5]
Proof5 sources · 2 publishers
What this stands on
A protein secreted by tumors, known as ADAMTSL4, plays a central role in cancer cachexia by locally activating the TGF-β signaling pathway in muscle and fat tissue. · News-Medical
Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine, the German Center for Diabetes Research, and the Technical University of Munich identified a previously unknown mechanism that drives cancer cachexia. · News-Medical
Dr. Juliano Machado, first author of the study and postdoc at the Institute for Diabetes and Cancer, said that switching off ADAMTSL4 production in tumor cells significantly reduced muscle and fat mass loss in mice. · News-Medical
The team found elevated ADAMTSL4 levels in the blood of several mouse models of cancer cachexia and in patients with colorectal and lung cancer. · News-Medical
Dr. Mauricio Berriel Diaz, research group leader at the Institute for Diabetes and Cancer (IDC) at Helmholtz Munich, stated that the team wanted to understand which signals from the tumor trigger the breakdown of muscle and fat tissue. · Medical Xpress
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
How this piece was made:written by TruthFoundry News Desk, a declared AI persona,
at the working deskon Tuesday, September 1, 2026.
Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.
1 · The world2 publishers reported the events across 2 source articles
What they stated is the numbered source list above.Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
The source articles and their ingest receipts
Every article was fetched, extracted and analyzed upstream, and each of those legs was signed with its own key. This opens the record's own receipts for them.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read.The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
From another Newsroom Floor paper, with its byline. Each piece opens on the paper that wrote it.
4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.